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Abstract
Background: Chemotherapy of cholangiocarcinoma (CCA), a devastating cancer with increasing worldwide
incidence and mortality rates, is largely ineffective. The discovery and development of effective chemotherapeutics
is urgently needed.
Methods/Design: The study aimed at evaluating anticancer activities, toxicity, and pharmacological activities of the
curcumin compound (CUR), the crude ethanolic extracts of rhizomes of Zingiber officinale Roscoe (Ginger: ZO) and
Atractylodes lancea thung. DC (Khod-Kha-Mao: AL), fruits of Piper chaba Hunt. (De-Plee: PC), and Pra-Sa-Prao-Yhai
formulation (a mixture of parts of 18 Thai medicinal plants: PPF) were investigated in animal models. Anti-
cholangiocarcinoma (anti-CCA) was assessed using CCA-xenograft nude mouse model. The antihypertensive,
analgesic, anti-inflammatory, antipyretic, and anti-ulcer activities and effects on motor coordination were
investigated using Rota-rod test, CODA tail-cuff system, writhing and hot plate tests, carrageenan-induced paw
edema test, brewer’s yeast test, and alcohol-induced gastric ulcer test, respectively. Acute and subacute toxicity
tests were performed according to the OECD guideline for testing of chemicals with modification.
Results: Promising anticancer activity against CCA in nude mouse xenograft model was shown for the ethanolic
extract of AL at all oral dose levels (1000, 3000, and 5000 mg/kg body weight) as well as the extracts of ZO, PPF,
and CUR compound at the highest dose level (5000, 4000, and 5000 mg/kg body weight, respectively). PC
produced no significant anti-CCA activity. Results from acute and subacute toxicity tests both in mice and rats
indicate safety profiles of all the test materials in a broad range of dose levels. No significant toxicity except
stomach irritation and general CNS depressant signs were observed. Investigation of pharmacological activities of
the test materials revealed promising anti-inflammatory (ZO, PPF, and AL), analgesic (CUR and PPF), antipyretic
(CUR and AL), antihypertensive (ZO and AL), and anti-ulcer (CUR, ZO, and AL) activities.
Conclusion: Plants used in Thai traditional medicine for the treatment of various ailments may provide reservoirs
of promising candidate chemotherapeutics for the treatment of CCA.
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Background
Cholangiocarcinoma (CCA) is a devastating cancer with
increasing worldwide incidence and mortality rate. It is
an important public health problem in several parts of
Southeast Asia, particularly in the northeastern region
of Thailand. The major cause of CCA in Thailand is the
consumption of improperly cooked and fermented fresh
water cyprinoids fish called “Pla-ra” or “Pla-som”,w h i c h
contains Opisthorchis viverrini (OV) and nitrosamine.
Lack of effective diagnostic tool and chemotherapeutics
are the major constraints for controlling this type of
cancer. Chemotherapy of CCA is largely ineffective and
clinical efficacy of the standard treatment with 5-fluor-
ouracil (5-FU) is low. Furthermore, the resistance of
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blem [1]. The discovery and development of chemother-
apeutics that are effective for the treatment and control
of CCA is urgently needed.
Throughout history, natural products have afforded a
rich repository of remedies with diverse chemical struc-
tures and bioactivities against several heath disorders
including cancer. It is estimated that 122 drugs from 94
plant species have been discovered through ethnobotani-
cal leads [2]. Additionally, the use of herbs as comple-
mentary and alternative medicine has increased
dramatically in the last 20-25 years. According to the
World Health Organization (WHO), traditional medi-
cines are relied upon by 65-80% of the world’sp o p u l a -
tion for their primary health care needs [2]. In a
previous study [3], we screened a total of 28 plants and
5 herbal formulations used in Thai traditional medicine
for the treatment of various ailments for their cytotoxic
activities against human CCA cell line CL-6. Ethanolic
extracts of 5 plants (rhizomes of Zingiber officinale Ros-
coe and Atractylodes lancea thung. DC, fruits of Piper
chaba Hunt., flowers of Mesua ferrea, and leaves of
Kaemferia galangal) and 1 herbal formulation (Pra-Sa-
Prao-Yhai) showed promising activities against CL-6 cell
line with IC50 (concentration that inhibits cell growth by
50%) values of less than 50 μg/ml.
In our effort to search for new herbal medicines with
promising activity against CCA, we further investigated
the in vivo anti-CCA, including the pharmacological
activities (motor coordination, antihypertension,
analgesia, anti-inflammation, anti-ulcer, and anti-pyr-
exia) of the ethanolic extracts of rhizomes of Zingiber
officinal Roscoe (ZO), Atractylodes lancea thung. DC
(AL), fruits of Piper chaba Hunt. (PC), and Pra-Sa-
Prao-Yhai formulation (PPF) in CCA-xenograft nude
mouse model. Due to the potential therapeutic interest
for the treatment of cancer, the anti-CCA and pharma-
cological activities of curcumin (CUR), the phenolic
compound isolated from rhizome of Curcuma longa
Linn. was also investigated. ZO, commonly known as
ginger, is a familiar condiment for various foods and
beverages and is used in folk medicine in Asia and in
tropical areas for various purposes such as relief for
colds, fevers, and digestive problems and as treatment
for nausea and vomiting as well as for arthritis. Some
pungent constituents present in ZO possess potent
antioxidant and anti-inflammatory activities and some
of them exhibit cancer preventive activity in experi-
mental carcinogenesis [4]. AL, the dried rhizome of A.
lancea thung. DC called “Cang Zhu” in China or
“Khod-Kha-Mao” in Thailand, has traditionally been
used as a stomachic in China and Japan [5]. PC, the
fruit of P. chaba Hunt. commonly called “Dee Plee”,
has been used in Thai medicine as an anti-flatulent,
expectorant, carminative, antitussive, antifungal, uterus
contracting agent, sedative-hypnotic, appetizer, coun-
ter-irritant, and is also useful in asthma, bronchitis,
fever, and inflammation [6]. PPF is a Thai traditional
medicine used for the treatment of fever in children
[7]. This remedy consists of a mixture of various parts
of 18 medicinal plants as described in Table 1.
Results
Toxicity study
For CUR, ZO, and AL, the maximum tolerated, includ-
ing the medium and low dose levels that produced no
significant sign of toxicity or death in the acute and
sub-acute toxicity tests, were 5,000, 3,000, and 1,000
mg/kg body weight, respectively. The maximum toler-
ated, medium and low dose levels of PPF, were 4,000,
2,000, and 1,000 mg/kg body weight. The corresponding
dose levels for PC were 1,000, 500, and 100 mg/kg body
weight, respectively. In all these cases, no significant
toxicity, except stomach irritation and general CNS
depressant signs (reduced alertness and locomotion and
diminished response to touch and balance) was
observed. Stomach irritation was observed in all animals
immediately after feeding them with the highest dose of
test materials but the symptom subsided within 2 hours
of administration.
Anti-cholangiocarcinoma activity
Tumor volume
To assess the inhibitory activities of the test materials
(CUR compound and plant extracts) on tumor growth,
CL-6 cells were injected subcutaneously into the lower
flanks of the CCA-xenografted nude mice. Tumor
growth inhibition was most evident in the mice treated
with AL at all dose levels, of which less than 10% of the
tumor size of the control group was observed on day 40
(Figure 1). The highest dose level (5,000 mg/kg body
weight) of CUR, ZO, PC, and PPF exhibited low activ-
ities on day 48 (40.5, 35.8, 16.1, and 21.2% tumor
volume of the control group, respectively). Mean (±
SEM) of tumor volumes for the control and the groups
treated with 5-FU, CUR, ZO, AL, PC, and PPF were
20,661 ± 126, 15,789 ± 101, 12,290 ± 144, 13,270 ± 130,
550 ± 13, 17,347 ± 116, and 16,290 ± 116 mm
3,r e s p e c -
tively. Representative tumors of CCA-xenografted mice
following administration of test materials are shown in
Figure 2.
Survival time
CCA-xenografted nude mice receiving AL at all dose
levels had a significant (p < 0.001) prolongation of survi-
val time (mean ± SEM) over 80 days (83.3 ± 0.88 days)
after tumor transplantation compared with the
untreated group (40.0 ± 0.57 days). The survival time of
mice receiving 5-FU, CUR, ZO, PC, and PPF were 55.0
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Page 2 of 17± 0.87, 64.3 ± 0.67, 64.7 ± 1.76, 43.0 ± 2.08, and 69.7 ±
0.88 days, respectively (Figure 3).
Histopathology
Histopathological findings revealed prominent inhibition
of lung metastasis by AL at the highest dose of 5,000
mg/kg body weight. Lung metastasis occurred in both
the untreated and treated mice but the intensity of lung
metastasis was significantly lower following a high dose
AL, with an average of less than 5% of the total lung
mass. In contrast, the metastasis covered about 90% of
the total lung mass of the untreated mice (Figure 4).
Mice receiving 5-FU, CUR, PC, and PPF developed lung
metastasis of 50, 60, 50, 80, and 40% of the total lung
mass, respectively.
Pharmacological activities
Motor coordination activity
Compared with the untreated group, a high dose level of
CUR, ZO, AL, PC, and PPF produced a significant (p <
0.001) interference with muscle relaxation similar to
that produced by 4 mg/kg body weight diazepam (Figure
5). The mean (± SEM) fall off time in the untreated and
the groups treated with diazepam, high dose level of
CUR, ZO, AL, PC, and PPF were at 353.3 ± 11.5, 25.5 ±
1.8, 75.6 ± 2.9, 58.4 ± 2.4, 35.4 ± 2.5, 41.9 ± 2.7, and
37.8 ± 2.6 sec, respectively.
Antihypertensive activity
High dose CUR, AL, PC, and the reference drug propa-
nolol (10 mg/kg body weight) significantly (p < 0.001)
decreased systolic (sBP) and diastolic (dBP) blood pres-
sure of rats following treatment with adrenaline (Table
2). Propanolol (10 mg/kg body weight) and all doses of
AL significantly (p < 0.001) reduced the heart rate of
rats compared with the baseline. For PC, only medium
(500 mg/kg body weight) and high (1,000 mg/kg body
weight) dose levels significantly (p < 0.001) decreased
heart rate. PPF and CUR had no effect on heart rate
reduction (Table 3). The effect of all test materials on
arterial blood pressure was similar to that observed with
the heart rate (Table 4).
Analgesic activity
The central analgesic activities (hot plate test) of the test
materials were supported by the results of the hot plate
tests. Oral administration of a high dose level of PPF
produced a significant (p < 0.001) prolongation of the
latency time to the heat stimulus (with potency of about
Table 1 Medicinal plants and herbal formulations under investigation
Family Plant Part
used
Voucher
specimen
Thai traditional Use
Zingiberaceae Zingiber officinale Roscoe. Rh SKP 206261501 Treatment of hypercholesteremia and high level
triglyceride
Compositae Atractylodes lancea (Thung.) DC. Rh SKP 051011201 Treatment of fever, colds, flu, sore throat
Piperaceae Piper chaba Hunt. Fr SKP 146160301 Used as carminative, antidiarrheal
Composition of Pra-Sa Prao-Yhai formulation:
Compositae Artemisia annua Linn. Rh SKP 051010101 Treatment of fever, hemorrhoids
Compositae Atractylodes lancea (Thung.) DC. Rh SKP 051011201 Treatment of fever, colds, flu, sore throat
Cruciferae Asclepias curassavica Linn. Fl SKP 057121901 Used as analgesic
Dracaenaceae Dracaena loureiri Gagnep. St, Ba SKP 065041201 Treatment of cough, fever, inflammation
Guttiferae Mammea siamensis Kosterm. Fl SKP 083131901 Restorative
Guttiferae Mesua ferrea Linn. Fl SKP 083130601 Treatment of dyspepsia
Myristicaceae Myristica fragrans Houtt. Sd SKP 121130601 Treatment of uterus pain, diarrhea
Myrtaceae Syzgium aromaticum (L.) Merr. & L.M.
Perry
Fl SKP 123190101 Treatment of toothache, bacterial infection
Nelumbonaceae Nigella sativa Linn. Sd SKP 160141901 Treatment of jaundice
Sapotadeae Mimusops elengi Linn. Fl SKP 171130501 Used as cordial, tonic. Treatment of syncope
Umbelliferae Angelica dahurica Benth. Rt SKP 199010401 Used as antipyretic, antiasthma, anticough
Umbelliferae Angelica sinensis (Oliv.) Diels Rh SKP 199010901 Treatment of bronchitis pleurisy
Umbelliferae Anethum graveolens Linn. Rt, Fr SKP 199010701 Used as carminative. Treatment of eye pain
Umbelliferae Cuminum cyminum Linn. Sd SKP 199030301 Treatment of dyspepsia, diarrhoea and jaundice
Umbelliferae Foeniculum vulgare Mill. var. dulce Alef. Sd SKP 199062201 Used as analeptic
Umbelliferae Ligusticum sinense Oliv. cv.
Chuanxiong
Rh SKP 199121901 Treatment of urinary bladder channel,, headache,
neurodermatitis
Zingiberaceae Amomum testaceum Ridl. Sd SKP 206011101 Used as carminative, antibacterial
Zingiberaceae Kaempferia galangal Lf SKP 206110701 Antinociceptive, anti-inflammatory
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Page 3 of 1750% of 5 mg/kg body weight morphine) compared with
the untreated control, starting 30 min until 60 min after
administration. CUR, AL, and PC did not produce any
significant central analgesic activities (Figure 6).
For peripheral analgesic activity (Writhing test), oral
administration of CUR compound at all dose levels sig-
nificantly (p < 0.01) inhibited the number of writhings
and stretching induced by 0.6% acetic acid given by
intraperitoneal injection with a potency of about 70-80%
of aspirin (200 mg/kg body weight). No significant per-
ipheral analgesic activity was observed with AL, PC, and
PPF (Figure 7).
Anti-inflammatory activity
Compared with the untreated control, indomethacin at a
dose of 10 mg/kg body weight significantly (p < 0.001)
reduced the paw edema volume induced by carrageenan,
starting three hours after administration. Similarly, PPF at
all dose levels also produced a significant (p < 0.01) anti-
inflammatory activity. AL exhibited significant (p <0 . 0 1 )
activity only at a high dose level whereas CUR exhibited sig-
nificant activity at medium and high dose levels (Figure 8).
Anti-ulcer activity
The anti-ulcer activities of all test materials on ethanol-
induced gastric lesion model are shown in Figure 9.
Figure 1 Anti-CCA activities indicated by inhibitory action on tumor volume (mean ± SEM: mm
3)o fC U Rc o m p o u n da n de x t r a c t so f
ZO, AL, PC, and PPF at various dose levels, in comparison with NSS (untreated control) and 5-FU (reference control) in CCA-
xenografted nude mice during the 48 days investigation period. Statistically significant difference by ANOVA, followed by post hoc scheffe
test: AL-treated group at low dose level vs. control group (p < 0.001). AL-treated group at medium dose level vs. control group (p < 0.001). AL-
treated group at high dose level vs. control group (p < 0.001). CUR-treated group at high dose level vs. control group (p < 0.01). ZO-treated
group at high dose level vs. control group (p < 0.01). PPF-treated group at high dose level vs. control group (p < 0.01). PC-treated group at high
dose level vs. control group (p < 0.01)
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observed in rats pre-treated with AL (p <0 . 0 0 1 )a n d
CUR (p < 0.001) at all dose levels compared to the
untreated control. Their potencies of activity were com-
parable to the reference drug omeprazole given at a
dose of 20 mg/kg body weight (93.04%) (Figure 10).
Antipyretic activity
The experimental rats showed a mean increase in about
1.4°C of rectal temperature, 17 hours after Brewer’s
yeast injection. PPF at 2,000 mg/kg body weight, and
ZO and AL at 5,000 mg/kg body weight produced a sig-
nificant (p < 0.01) antipyretic activity at 5 hours after
administration, whereas PPF at 4,000 mg/kg and aspirin
at 200 mg/kg body weight showed significant antipyretic
activity throughout the observation period starting from
3 up to 6 hours (Figure 11).
Discussion
The present study demonstrated promising anticancer
activity against CCA in nude mouse xenograft model of
the ethanolic extract of AL at all dose levels, as well as
the extracts of ZO, PPF, and CUR compound at the
highest dose level. PC produced no significant anti-CCA
activity. Results from the acute and subacute toxicity
tests both in mice and rats indicated safety profiles of
all test materials in a broad range of dose levels. No sig-
nificant toxicity, except stomach irritation and general
CNS depressant signs (reduced alertness and locomo-
tion, and diminished response to touch and balance),
was observed. Stomach irritation occurred in all animals
immediately after feeding them with a high dose of the
test materials. Investigation of pharmacological activities
of the test materials revealed promising anti-
Figure 2 Representative tumors of CCA-xenografted nude mice following treatment with the test materials (CUR compound and
extracts of ZO, AL, PC, and PPF at various dose levels) in comparison with untreated control and 5-FU (reference control).
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PPF), antipyretic (CUR and AL), antihypertensive (ZO
and AL), and anti-ulcer (CUR, ZO, and AL) activities.
The ethanolic extract of AL was shown to possess the
most potent anti-CCA activity similar to 5-FU with
regards to the reduction of tumor mass, prolongation of
survival time, and inhibition of lung metastasis. All dose
levels significantly reduced tumor size (by 97.3%), pro-
longed survival time (by 208.5%), and inhibited lung
metastasis (by 95% of total lung mass) compared with
the untreated control. To the best of our knowledge, the
present study is the first study that demonstrated the
anticancer activity of AL. Interestingly, AL extract
exhibited prominent inhibitory effect on lung metastasis.
Metastasis is one of the major problems in the treat-
ment of several cancer types. In severe stage CCA,
metastatic tumors in the lungs are CCA cancers which
developed in the lung tissues by spreading from the
liver origin through the bloodstream or lymphatic sys-
tem to the lungs. Histopathological examination at
autopsy revealed lung metastasis in all mice following
xenografting with CL-6. Significant reduction of lung
metastasis to only 5% of the total lung mass was
observed in the xenografted mice treated with AL (Fig-
ure 4) whereas metastasis of more than 90% of the total
lung mass was found in the untreated mice. The anti-
metastatic action of AL corresponded well with its
observed antihypertensive effects (reduction of systolic
and diastolic blood pressure, heart rate, and mean arter-
ial pressure). Furthermore, AL also exhibited anti-ulcer
(all dose levels), anti-inflammatory (high dose), and
Figure 3 Anti-CCA activities indicated by prolongation of
survival time (mean ± SEM), of CUR compound and extracts of
ZO, AL, PC, and PPF at various dose levels, in comparison with
NSS (untreated control) and 5-FU (reference control) in CCA-
xenografted nude mice during the 85 days investigation
period. Statistically significant difference by ANOVA, followed by
post hoc scheffe test: AL-treated group at low dose level vs. control
group (p < 0.001). AL-treated group at medium dose level vs.
control group (p < 0.001). AL-treated group at high dose level vs.
control group (p < 0.001).
Figure 4 Representative histopathology of lung metastasis of
CCA-xenografted nude mice following treatment with the test
materials (CUR compound and extracts of ZO, AL, PC, and PPF
at various dose levels) in comparison with untreated control
and 5-FU (reference control). % Metastasis of lung mass
represents mean (± SEM) from 6 mice for each group.
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cant anti-ulcer activity (96-98%) of AL confirms its use
to improve stomach damage partly through anti-ulcer
effects [8]. This anti-ulcer activity was more potent than
the reference drug omeprazole given at a dose of 20
mg/kg body weight. The compound 2-[(2’E)-3’,7’-
dimethyl-2’,6’-octadienyl]-4-methoxy-6-methylphenol
isolated from the rhizome of AL showed strong inhibi-
tory effects on 5-lipoxygenase (5-LOX) and cyclooxygen-
ase-1 (COX-1) [9], the two key enzymes responsible for
the metabolism of arachidonic acid, either to prostaglan-
dins and thromboxanes or to leukotrienes, which play a
central role in the regulation of different physiological
processes, but also cause pain, inflammation, and
hypersensitivity.
Significant anti-CCA activity of rhizome extract of ZO
w a sa l s oo b s e r v e di nt h ex e n o g r a f tm o u s em o d e l .H i g h
dose ZO significantly reduced tumor volume (by 35.8%),
and all dose levels significantly prolonged survival time
(by 161.5%) compared with the control group. Inhibition
of lung metastasis by about half was seen at high dose.
Furthermore, the extract possessed anti-inflammatory at
all dose levels. In our previous study, the anti-CCA
activity of ZO was demonstrated in OV/
Figure 5 Effect of test materials on locomotive activity
(represented by mean ± SEM of fall-off time in seconds) in rats
following treatment with the test materials (CUR compound
and extracts of ZO, AL, PC, and PPF at various dose levels) in
comparison with untreated control and diazepam (reference
control). Statistically significant difference by ANOVA, followed by
post hoc scheffe test: CUR-treated group at high dose level vs.
control group (p < 0.001). ZO-treated group at high dose level vs.
control group (p < 0.001). AL-treated group at high dose level vs.
control group (p < 0.001). PC-treated group at high dose vs. control
group (p < 0.001) PPF-treated group at high dose vs. control group
(p < 0.001). Diazepam-treated group vs. control group (p < 0.001).
Table 2 Effect of test materials and propanolol on systolic (sBP) and diastolic (dBP) blood pressure of rats
Group Dose
(mg/kg bw.)
Blood Pressure (mmHg)
Before induction of hypertension After induction of hypertension After treatment of hypertension
sBP dBP sBP dBP sBP dBP
Normal - 118 ± 0.4 81 ± 0.3 120 ± 0.3 82 ± 0.4 120 ± 0.3* 81 ± 0.4*
Untreated control - 119 ± 0.5 80 ± 0.4 178 ± 0.4 128 ± 0.4 181 ± 0.6 137* ± 0.4
Propanolol-treated 10 120 ± 0.6 81 ± 0.3 177 ± 0.4 131 ± 0.5 135 ± 0.4* 95 ± 0.4*
CUR 1000 119 ± 0.5 82 ± 0.3 178 ± 0.3 130 ± 0.4 164 ± 0.4 126 ± 0.3
3000 119 ± 0.4 79 ± 0.4 180 ± 0.4 131 ± 0.5 152 ± 0.3 121 ± 0.4
5000 118 ± 0.4 78 ± 0.3 179 ± 0.4 130 ± 0.4 136 ± 0.4* 101 ± 0.4*
ZO 1000 119 ± 0.5 81 ± 0.3 178 ± 0.5 130 ± 0.5 168 ± 0.3 119 ± 0.3
3000 120 ± 0.5 80 ± 0.3 180 ± 0.4 129 ± 0.5 163 ± 0.5 120 ± 0.5
5000 120 ± 0.4 81 ± 0.4 181 ± 0.5 128 ± 0.4 162 ± 0.4 119 ± 0.4
AL 1000 121 ± 0.5 79 ± 0.4 180 ± 0.4 131 ± 0.5 155 ± 0.3 109 ± 0.4
3000 118 ± 0.4 82 ± 0.4 179 ± 0.5 126 ± 0.5 156 ± 0.4 105 ± 0.5
5000 119 ± 0.3 81 ± 0.3 177 ± 0.4 169 ± 0.4 134 ± 0.4* 98 ± 0.3*
PC 100 117 ± 0.3 79 ± 0.4 180 ± 0.4 127 ± 0.5 180 ± 0.5 126 ± 0.4
500 118 ± 0.4 81 ± 0.3 177 ± 0.3 129 ± 0.4 170 ± 0.4 122 ± 0.4
1000 120 ± 0.5 80 ± 0.4 179 ± 0.4 128 ± 0.4 139 ± 0.3* 113 ± 0.4*
PPF 1000 119 ± 0.4 82 ± 0.4 179 ± 0.4 131 ± 0.4 169 ± 0.5 117 ± 0.3
3000 120 ± 0.5 79 ± 0.4 180 ± 0.5 130 ± 3.3 162 ± 0.4 121 ± 0.4
4000 119 ± 0.4 80 ± 0.3 181 ± 0.5 128 ± 0.5 162 ± 0.4 120 ± 0.5
Data are presented as mean ± SEM values
*Statistically significant difference with baseline by paired t-test:
sBP and dBP of CUR-treated group at high dose level (p < 0.001)
sBP and dBP of AL-treated group at high dose level (p < 0.001)
sBP and dBP of PC-treated group at high dose level (p < 0.001)
sBP and dBP of propanolol-treated group at high dose level (p < 0.001)
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The extract significantly prolonged survival time and
survival rate of the cancerous animals. The anticancer
properties of ZO have been attributed to the presence
of certain pungent vallinoids, viz. [6]-gingerol and [6]-
paradol, as well as some other constituents like shogaols
and zingerone [11]. A number of mechanisms that may
be involved in the chemopreventive activity of ZO and
its components have been reported from the laboratory
studies in various experimental models [11]. Various
studies have shown that a wide range of ZO constitu-
ents inhibit production of nitric oxide, inflammatory
cytokines and enzymes prostaglandin synthase, and ara-
chidonate-5-LOX in a dose-dependent manner. The lat-
ter in turn, inhibits the synthesis of leukotrienes from
both COX-1 and COX-2 and LOX, respectively [12].
ZO has also demonstrated a significant reduction of
inflammation in animals compared with conventional
drugs [12]. A significant anti-ulcer activity of the etha-
nolic extract of ZO was also observed. In a previous
study [13], the gastroprotective effect of 50% ethanolic
extract of ZO was assessed in rats in the ethanol and
acetic acid-induced ulcer models at different doses (500
mg/kg and 1.5-5 g/kg body weight, respectively). The
extract showed a dose-dependent inhibition of the ulcer
index in ethanol and acetic acid-induced ulcers. It pre-
vented the oxidative damage of the gastric mucosa by
blocking lipid peroxidation and by a significant decrease
in superoxide dismutase and increase in catalase activity.
The anti-CCA activity of PPF extract was moderate;
nevertheless, it exhibited diverse pharmacological activ-
ities. High dose PPF significantly reduced tumor
volume and prolonged survival time compared with
the untreated group. Inhibition of lung metastasis
occurred on an average 60% of the lung mass. The
anticancer activity of PPF is likely to be due to the
activities of various components in the formulation.
Recently, we demonstrated the cytotoxic activity
against CL-6, a CCA cell line, of the two components
of PPF: Mimusops elengi Linn. (flower) (IC50 = 48.53
μg/ml) and Kaempferia galangal ("Proh-hom” in Thai;
leaf) (IC50 = 37.36 μg/ml) [3]. In addition, previous in
vitro and in vivo studies reported the anticancer poten-
tial of Nigella saliva (commonly known as black seed
or black cumin) [14], Angelica sinensis (Oliv.) Diels
[15], Anethum graveolens Linn. [16], Foeniculum vul-
gare Mill. [17], Angelica dahurica Benth. [18], Mam-
mea siamensis Kosterm.[ 1 9 ] ,Myristica fragrans Houtt.
Table 3 Effect of test materials and propanolol (reference control) on heart rate of rats
Group Dose
(mg/kg bw.)
Heart rate (beat/min)
Before induction of hypertension After induction of hypertension After treatment of hypertension
Normal - 412 ± 4.3 415 ± 4.1 409 ± 4.5
Untreated control - 399 ± 4.1 535 ± 5.4 570 ± 5.8
Propanolol-treated 10 410 ± 4.4 520 ± 5.5 405 ± 4.4
CUR 1000 411 ± 4.5 530 ± 5.5 530 ± 5.5
3000 401 ± 4.2 528 ± 5.3 518 ± 5.6
5000 390 ± 3.9 523 ± 5.4 471 ± 4.3
ZO 1000 420 ± 4.2 526 ± 4.9 499 ± 5.1
3000 418 ± 4.9 531 ± 5.7 474 ± 5.2
5000 415 ± 4.6 530 ± 5.5 416 ± 4.1*
AL 1000 403 ± 4.1 544 ± 5.4 431 ± 4.4*
3000 407 ± 4.3 540 ± 5.6 416 ± 4.3*
5000 398 ± 3.6 528 ± 5.3 410 ± 4.5*
PC 100 409 ± 4.0 537 ± 5.2 540 ± 5.6
500 410 ± 4.2 519 ± 5.3 427 ± 4.1*
1000 420 ± 4.5 509 ± 5.3 419 ± 4.6*
PPF 1000 412 ± 4.5 519 ± 5.2 559 ± 5.8
2000 398 ± 4.7 534 ± 5.6 544 ± 5.7
4000 405 ± 4.4 526 ± 5.5 536 ± 5.4
Data are presented as mean ± SEM values
*Statistically significant difference with baseline by paired t-test:
sBP and dBP of ZO-treated group at high dose level (p < 0.001)
sBP and dBP of AL-treated group at all dose levels (p < 0.001)
sBP and dBP of PC-treated group at medium and high dose levels (p < 0.001)
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Page 8 of 17[20], and Syzygium aromaticum Linn. (cloves) [21].
The bioactive compound derived from N. sativa oil is
thymoquinone, which was shown to exhibit anti-tumor
activities, including anti-proliferative and pro-apoptotic
effects on cell lines derived from breast, colon, ovary,
larynx, lung, myeloblastic leukemia, and osteosarcoma
[22-26]. Mechanistically, thymoquinone reportedly
induced apoptosis in tumor cells by suppressing NF-
B, Akt activation and extracellular signal-regulated
kinase signaling pathways, and also inhibits tumor
angiogenesis [27]. Recently, the serine/threonine Polo-
like kinases (Plk) which are over-expressed in many
types of human cancers have been identified as targets
for thymoquinone. Cytotoxic activity towards several
cell lines in vitro including apoptotic activity was also
shown with a novel polysaccharide isolated from a rhi-
zome of A. sinensis (Oliv.) Diels named APS-1 d [15].
Among the coumarins isolated from the bark of M.
siamensis Kosterm, theraphin C showed the strongest
inhibitory activity on cell proliferation in DLD-1 (colon
cancer), MCF-7 (breast adenocarcinoma), HeLa
(human cervical cancer), and NCI-H460 (human lung
cancer) cell lines [19].
With regards to the pharmacological activities of PPF,
anti-inflammatory and CNS suppression effects were
observed at all doses, whereas reduction of blood pres-
sure and analgesic effects were shown at high dose and
antipyretic effect was shown at the medium dose level
of 2,000 mg/kg body weight. Promising antipyretic, anti-
hypertensive, anti-inflammatory, and analgesic activities
of various components of PPF have previously been
shown. For example, the seed of N. sativa was shown to
exhibit antihypertensive property [14]. The anti-inflam-
matory action of nutmeg has been shown to be due to
the myristicin that it contains [28]. Anti-inflammatory
effect of thymoquinone from the seed of N. sativa was
shown to be due to the inhibitory effect on eicosanoid
generation, namely thromboxane B2 and leukotrienes
B4, by inhibiting both COX and LOX enzymes, respec-
tively [29]. The ethanol fractions of A. sinensis (Oliv.)
Diels and A. dahurica were shown to exert an anti-
inflammatory effect through the suppression of NF-B-
dependent activity [30]. Flavonoids and stilbenoids iso-
lated from the stem wood of D. loureiri were shown to
exhibit COX-1 and COX-2 inhibitory activity [31]. The
anti-inflammatory mechanisms of byakangelicin, the
Table 4 Effect of test materials and propanolol (reference control) on mean arterial blood pressure of rats
Group Dose
(mg/kg bw.)
Mean arterial pressure (mmHg)
Before induction of hypertension After induction of hypertension After treatment of hypertension
Normal - 107 ± 3.1 110 ± 3.4 109 ± 2.7
Untreated control - 108 ± 3.4 143 ± 2.7 151 ± 3.0
Propanolol-treated 10 110 ± 3.2 145 ± 3.1 116 ± 2.5*
CUR 1000 106 ± 0.4 145 ± 0.3 138 ± 0.5
3000 104 ± 0.3 146 ± 0.4 137 ± 0.4
5000 107 ± 0.3 148 ± 0.3 135 ± 0.4
ZO 1000 105 ± 0.3 144 ± 0.4 135 ± 0.5
3000 107 ± 0.4 147 ± 0.5 137 ± 0.3
5000 106 ± 0.3 148 ± 0.4 119 ± 0.3*
AL 1000 105 ± 0.3 148 ± 0.5 118 ± 0.4*
3000 107 ± 0.4 144 ± 0.4 120 ± 0.4*
5000 106 ± 0.3 148 ± 0.4 122 ± 0.3*
PC 100 103 ± 0.3 147 ± 0.3 134 ± 0.5
500 105 ± 0.4 149 ± 0.4 124 ± 0.4*
1000 105 ± 0.4 147 ± 0.4 125 ± 0.4*
PPF 1000 104 ± 0.3 145 ± 0.4 134 ± 0.3
2000 108 ± 0.4 146 ± 0.5 134 ± 0.4
4000 104 ± 0.4 143 ± 0.5 134 ± 0.5
Data are presented as mean ± SEM values
*Statistically significant difference with baseline by paired t-test:
sBP and dBP of ZO-treated group at high dose level (p < 0.001)
sBP and dBP of AL-treated group at all dose levels (p < 0.001)
sBP and dBP of PC-treated group at medium and high dose levels (p < 0.001)
sBP and dBP of propanolol-treated group (p < 0.001)
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Page 9 of 17active component of A. dahurica Benth, involve the
inhibition of tumour necrosis factor-a, histamine
release, and of PGE2 through decreased COX-2, besides
its potent antioxidant effects [32]. The analgesic activity
of PPF observed in the present study was found to be
centrally acting. The antinociceptive effects of N. sativa
oil and the active compound thymoquinone were shown
to be through indirect activation of the superspinal mu1
and kappa opioid receptors [33].
Recent studies have substantiated and provided scientific
evidence regarding the prophylactic and therapeutic
potential of CUR as anticancer in several types of cancer
including colon, lung, breast, liver, and prostate. Interest-
ingly, the anticancer activity of CUR against CCA in the
hamster model was reported recently [34]. The compound
exhibited an anticarcinogenic potential via increasing the
survival of hamsters, suppression of the various events
involved in multiple steps of carcinogenesis such as tran-
scription factor, NF-B, AP-1, and STAT-3, and ability to
suppress pro-inflammatory pathways on COX-2 and
iNOS. In the present study, the CUR compound was
shown to possess moderate anti-CCA activity. High dose
significantly reduced tumor volume (by 40.5%) and
Figure 7 Peripheral analgesic activity (represented by mean ±
SEM) number of writhing and stretching in writhing test) of
CUR compound and extracts of ZO, AL, PC, and PPF at various
dose levels, in comparison with untreated control and aspirin
(reference control). Statistically significant difference by ANOVA,
followed by post hoc scheffe test: CUR-treated group at low dose
level vs. control group (p < 0.01). CUR-treated group at medium
dose level vs. control group (p < 0.001). CUR-treated group at high
dose level vs. control group (p < 0.001). Aspirin-treated group vs.
control group (p < 0.001).
Figure 6 Central analgesic activity (represented by mean ± SEM of analgesic response in hot plate test) of CUR compound and
extracts of ZO, AL, PC, and PPF at various dose levels, in comparison with untreated control and aspirin (reference control). Statistically
significant difference by ANOVA, followed by post hoc scheffe test: PPF-treated group at high dose level vs. control group (p < 0.01). Aspirin-
treated group vs. control group (p < 0.001).
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Page 10 of 17inhibited lung metastasis (by 60%). All doses significantly
prolonged survival time (by 160.8%) compared with the
control group. Undisputed scientific evidence suggests
that CUR suppresses all three stages of carcinogenesis:
initiation, promotion, and progression [34]. Due to a vast
number of biological targets with virtually no side effects,
CUR has achieved the potential therapeutic interest to
cure immune related, metabolic diseases, and cancer. The
intricate mechanism of action of CUR involves various
biological targets viz transcription factors: NF-AT, AP-1,
signal transducers and activator of transcription (STAT),
p53 and kinases: mitogen-activated protein kinases, cyto-
kines release, and the receptors found on different
immune cell type. These actions of CUR greatly affect the
innate and adaptive arms of immunity especially in the
pathological conditions [34]. The peripheral analgesic and
anti-ulcer effects were shown in this study following all
dose levels of CUR. Surprisingly, no significant anti-
inflammatory activity was observed. The analgesic activity
of CUR is consistent with the previous findings of suppres-
sion of nociception in both tail flick and acetic acid-
induced writhing tests following intraperitoneal injection
of CUR extract [35]. Tuorkey and Karolin (2009) [36]
demonstrated the anti-ulcer activity of curcumin that was
displayed by attenuating the different ulcerative effectors
including gastric acid hyper-secretion, total peroxides,
myeloperoxidase (MPO) activity, IL-6, and apoptotic
incidence.
Figure 8 Inflammatory activity (represented by mean ± SEM change of edema volume in l-carrageenan-induced paw edema test) of
CUR compound and extracts of ZO, AL, PC, and PPF at various dose levels, in comparison with untreated control and indomethacin
(reference control). Statistically significant difference by ANOVA, followed by post hoc scheffe test: CUR-treated group at low dose level vs.
control group (p < 0.01). CUR-treated group at medium dose level vs. control group (p < 0.01). CUR-treated group at high dose level vs. control
group (p < 0.01). Aspirin-treated group vs. control group (p < 0.001).
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T h er e s u l t ss u g g e s tt h a tp l a n t su s e di nT h a it r a d i t i o n a l
medicine for the treatment of various ailments may
provide reservoirs of promising candidate
chemotherapeutics for the treatment of CCA. In addi-
tion, results from pharmacological activity tests ratio-
nalize the ethnomedical use of this plant in a number
of ailments. These plants have multiple pharmacologi-
cal actions on various human physiological systems
that would support the treatment of chronic disease
like cancer. Moreover, the use of herbal medicines is
safe compared with synthetic drugs. Further studies
are required to determine the molecular mechanisms
and active ingredients of all test materials particularly
AL, which are responsible for their anti-CCA activities.
Methods
Chemicals and reagents
Commercial grade ethanol and acetic acid were pur-
chased from RCI Labscan Co. Ltd. (Pathumwan, BKK,
THA). The cell culture medium RPMI, fetal bovine
s e r u m( F B S ) ,d i m e t h y l s u l f o x i d e( D M S O ) ,a n dt h ea n t i -
biotics-antimycotics were purchased from Gibco BRL
Life Technologies (Grand Isl a n d ,N Y ,U S A ) .C u r c u m i n
(CUR) compound, 5-fluorouracil (5-FU), propanolol,
aspirin, indomethacin, omeprazole, paracetamol,
brewer’s yeast, l-carrageenan, and Tween-80 were pur-
chased from Sigma-Aldrich Inc. (St. Louis, MO, USA).
Adrenaline injection was purchased from the Govern-
ment Pharmaceutical Organization of Thailand (GPO).
Preparation of plant extracts
Plant materials were collected from various parts of
Thailand and some were purchased from city markets.
Authentication of plant materials were carried out at the
herbarium of the Department of Forestry, Bangkok,
Thailand, where the herbarium vouchers have been
kept. A duplicate set was also deposited in the herbar-
ium of Southern Center of Thai Medicinal Plants at the
Faculty of Pharmaceutical Sciences, Prince of Songkhla
University, Songkhla, Thailand. Preparation of the etha-
nolic extracts of all plant materials were performed
according to the previously described method [3]. All
extracts were standardized using high performance
liquid chromatography to examine the amounts of active
ingredients. The ethanolic extract yields of ZO, AL, PC,
and PPF were 4.3, 16.89, 10.89, and 18.66%. Quantitative
analysis of marker compounds of the ethanolic extracts
of ZO (6-gingerol), AL (b-eudesmol), PC (piperine), and
PPF (acetoxychavicol acetate) revealed 6.18, 6.64, 7.0,
and 10.45% of the total crude extract, respectively.
Cell line and culture
The CCA cell line CL-6 used for in vivo tumor xeno-
graft was cultured in RPMI medium supplemented with
10% heated fetal bovine serum and 100 IU/ml of anti-
anti and were maintained at 37°C in a 5% CO2 atmo-
sphere with 95% humidity.
Figure 9 Observed ulcer area in gross appearance and
inhibition percentage in rats.
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Male and female ICR and BALB/c-nude mice (6 weeks of
age, weighting 20-25 g) and Wistar albino rats (6 weeks of
age, weighting 120-130 g) were purchased from The
National Laboratory Animal Centre of Thailand. They
were housed under standard conditions and fed with a
stock diet and water ad libitum. Approval of the study
protocol was obtained from the Ethics Committee for
Research in Animals, Thammasat University, Thailand.
Evaluation of acute and subacute toxicity
Acute and subacute toxicity tests were performed in
mice and rats according to the OECD guideline for
chemicals with modification in order to obtain the three
dose levels (maximum tolerated dose, medium dose, and
low dose) of each test material which did not cause any
sign of serious toxicity or death [37]. These three toler-
ated dose levels were further used for assessment of the
anti-CCA and pharmacological activities of each test
material. ICR mice and Wistar albino rats (5 males and
5 females for each group) were fed (via gastric gavage)
with three dose levels (low, medium, and high) of the
test materials (resuspended in a mixture of distilled
water and Tween-80, 4:1, v:v). The maximum dose
started from 5,000 mg/kg body weight. The control ani-
mals were fed with a mixture of distilled water and
Figure 10 Anti-ulcer activity (represented by mean ± SEM of ulcer area and % inhibition of ulcer area in ethanol-induced gastric ulcer
test) of CUR compound and extracts of ZO, AL, PC, and PPF at various dose levels, in comparison with untreated control and
omeprazole (reference control). Statistically significant difference by ANOVA, followed by post hoc scheffe test: CUR-treated group at low dose
level vs. control group (p < 0.001). ZO-treated group at medium dose level vs. control group (p < 0.001). AL-treated group at high dose level vs.
control group (p < 0.001). PPF-treated group at high dose level vs. control group (p < 0.001). Omeprazole-treated group vs. control group (p <
0.001).
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Page 13 of 17Tween-80. Animals were closely observed for signs of
toxicity during the first 30 minutes, periodically during
the first 24 hours and then daily for 14 days (acute toxi-
city) or 30 days (subacute toxicity). At the end of the
observational period, all animals were sacrificed under
ether anesthesia and vital organs (brain, heart, kidneys,
liver, spleen, stomach, large and small intestine, and
lungs) were removed from all animals for gross and his-
topathological examination.
Assessment of anti-CCA activity in nude mouse xenograft
model
T h eC C Ac e l ll i n eC L - 6( 1×1 0
6 cells) was used for
xenografting all nude mice. Cells were removed from
culture flask by trypsinization, collected in a 50 ml coni-
cal tube and centrifuged at 100 × g for 10 min. Superna-
tant was removed and cells were resuspended in 5 ml of
complete media and cell number was counted using
hemocytochamber. Cells for injection were prepared by
diluting cell suspension to obtain 1 × 10
6 cells/200 μl
normal saline (0.85% NaCl) and injected subcutaneously
into the flanks of the nude mice (1 × 10
6 cells in 200
μl). Tumors were allowed to develop for 14 days until
they reached approximately 50 mm
3 tumor volume.
Tumor volume was measured using a caliper and body
weight was recorded once every three days (Figure 12).
To evaluate the anti-CCA activity of CUR compound
and each plant extract, CCA-xenografted nude mice
Figure 11 Antipyretic activity (represented by mean ± SEM of rectal temperature in brewer’s yeast induced pyrexia test) of CUR
compound and extracts of ZO, AL, PC, and PPF at various dose levels, in comparison with untreated control and omeprazole
(reference control). Statistically significant difference by ANOVA, followed by post hoc scheffe test: PPF-treated group at medium dose level vs.
control group (p < 0.01). ZO-treated group at high dose level vs. control group (p < 0.01). PC-treated group at high dose level vs. control group
(p < 0.01). PPF-treated group at high dose level vs. control group (p < 0.01). Aspirin-treated group vs. control group (p < 0.001).
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Page 14 of 17were divided into groups of 6 males for each dose
level, matched-pair according to tumor size and body
weight after tumor nodules reached the volume of
approximately to 50 mm
3. All the test materials were
g i v e na tt h et h r e ed o s el e v e l s( l o w ,m e d i u m ,a n dh i g h )
based on the maximum tolerated dose observed in the
toxicity test. AL, ZO, and CUR were given at the doses
of 1,000 (low), 3,000 (medium), and 5,000 (high) mg/
kg body weight. PC was given at the doses of 100
(low), 500 (medium), and 1,000 (high) mg/kg body
weight. PPF was given at the doses of 1,000 (low),
2,000 (medium), and 4,000 (high) mg/kg body weight.
Each test material was fed to animals by intragastric
tube (0.3 ml) daily for 30 days. The untreated and 5-
FU treated control groups were given an equal volume
of normal saline daily for 30 doses and 5-FU (40 μg/
ml) for 14 doses, respectively. On day 0 (the day of
first dose), 2, 5, 8, 11, 14, 18, 21, 24, and 28 animals
were weighed on a triple-beam balance and tumor size
was measured in two linear dimensions (maximum
longitudinal and transverse diameters) using calipers
with accuracy of 0.1 mm. The tumor volume was cal-
culated from the formula: tumor volume = (length)
(width)
2/2.
Autopsy and histopathological examination
For both toxicity and anticancer activity evaluation, all
internal organs were removed from the animals at
autopsy and observed macroscopically. Samples were
fixed with 10% formalin solution. Specimens were
washed in phosphate buffer three times, then dehy-
drated in an ascending series of ethanol for 15 min each
and embedded in paraffin, followed by sectioning and
staining with hematoxylin and eosin [38].
Assessment of pharmacological activities
Each test material was administered orally to all animals
(ICR mice or rats) in the form of suspension of water
and 1% sodium carboxy methyl cellulose (SCMC). Ani-
mals were divided into groups of six males each. Each
test material was given at thet h r e ed o s el e v e l s( l o w ,
medium, and high) as described previously for the
assessment of anti-CCA activities. The untreated control
group received 10 ml/kg body weight of 1% SCMC
while the positive control group received the reference
drug for each test at an appropriate dose.
Locomotive activity
Rota-rod test was applied to assess the effect of CUR
compound and plant extracts on motor coordination
[39]. Mice were trained to remain for 3 min on the rod
rotating at a speed of 25 rpm. On the following day,
each test material, 1% SCMC (untreated control) and 4
mg/kg body weight diazepam (reference control), was
administered orally to each mouse and its ability to
remain on the rotating rod was assessed before and 30
min after the oral administration. The fall-off time (sec)
from the rod was noted for each animal.
Antihypertensive activity
Rats were injected intraperitoneally with 0.1 ml of adre-
naline using a 1-ml disposable syringe for five consecu-
tive days to induce hypertension [40]. Test materials,
reference drug propanolol, and 1% SCMC were given by
oral administration for seven days. Blood pressure, heart
rate, and mean arterial pressure were measured using
CODA tail-cuff recorder (Kent Scientific, Torrington,
CON, USA) machine in three steps, i.e., before treat-
ment, one day after the last dose of adrenaline, and one
day after the last dose of test materials or propanolol or
1% SCMC.
Analgesic activity
The analgesic activity of the test materials were evalu-
ated using hot plate test [41] and writing test [42] for
central and peripheral analgesic activity, respectively.
For the hot plate test, mice were placed to the beaker
(on a hot plate) maintained at 55°C ± 1°C in order to
obtain their response to electrical heat-induced nocicep-
tive stimulus. Latency of analgesic response character-
ized by manifestation of signs of acute discomfort, e.g.,
licking of a hind limb or jumping was observed. Starting
at thirty minutes after oral administration of each test
material or 1% SCMC (untreated control), the analgesic
response was measured at 15, 30, 45, and 60 min period.
For the reference control group, morphine sulfate at a
dose of 5 mg/kg body weight was injected subcuta-
neously into each mouse and the analgesic response was
measured. Only mice that remained on the rod during
the 15-45 minutes were used for initial screening and
the cut-off time of 15 sec was used to evaluate analgesic
activity of each test material.
Figure 12 Schematic diagram representing treatment sequence
for the evaluation of anticancer activity of CUR compound and
plant extracts in CCA-xenografted nude mouse model. Cells
injected = subcutaneous injection of CL-6; Treatment started =
administration of treatment (CUR compound, each plant extract,
vehicle or 5-FU); Treatment stopped = withdrawal of treatment
(CUR compound, each plant extract, normal saline or 5-FU).
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materials, the reference analgesic drug aspirin (200 mg/
kg) or vehicle control (1% SMC) were orally adminis-
tered to all mice 30 min before the intraperitoneal injec-
tion of 0.6% acetic acid (10 mg/kg body weight). The
number of writhings and stretchings were counted over
a 20 min period.
Anti-inflammatory activity
Carrageenan-induced paw edema was used to investigate
the anti-inflammatory activity of the test materials [43].
The initial right hind paw volume of the rats was mea-
sured using a plethysmometer (Ugo Basile, Comerio,
V A ,I t a l y )a n dt h e n0 . 1m lo f1 %( w / v )l-carrageenan
was subcutaneously injected into the subplantar region
of the right hind paw. The volume of the right hind paw
was measured at 1, 2, 3, 4, and 5 hr after carrageenan
injection. Test materials, vehicle or reference drug indo-
methacin (10 mg/kg body weight) were orally adminis-
tered 30 min before carrageenan injection.
Anti-ulcer activity
The rats were fasted for 48 hours but were allowed free
access to drinking water up to 2 hours before the
experiment. Gastric ulcer was induced by orogastric
intubation of absolute ethanol according to the method
of De Pasquale et al. (1995) with modification [44]. The
reference control group received an oral dose of 20 mg/
kg body weight omeprazole in 1% SCMC (in volume of
5 ml/kg body weight). One hour after pre-treatment
with test materials or omeprazole or 1% SCMC, all
groups of rats were gavaged with absolute ethanol to
induce gastric ulcer. The rats were euthanized by cervi-
cal dislocation 60 min later using diethyl ether and their
stomachs were immediately excised. Ulcers found in the
gastric mucosa appeared as elongated bands of hemor-
rhagic lesions parallel to the long axis of the stomach.
Each specimen of gastric mucosa was thus examined for
damage. The length (mm) and width (mm) of the ulcer
on the gastric mucosa were measured under a micro-
scope. The size of each ulcer lesion was measured and
the sum of the areas of all lesions for each stomach was
applied in the calculation of the ulcer area (UA),
w h e r e i nt h es u mo fs m a l ls q u a r e s×4×1 . 8i se q u a lt o
UA mm
2 as described previously by Kauffman and
Grossman (1978) with modification [45]. The inhibition
percentage (I%) was calculated as follow:
(I%) =[ ( U A control − UAtreated)/UAcontrol] × 100%.
Antipyretic activity
The antipyretic activity of the test materials was evalu-
ated using Brewer’s yeast-induced pyrexia in rats [44].
Fever was induced in all rats by subcutaneous injection
of 20 ml/kg boy weight of 20% aqueous suspension of
Brewer’s yeast in normal saline. All test materials,
vehicle control (1% SCMC), and reference drug parace-
tamol (150 mg/kg body weight) were administered orally
17 hours after the induction of fever. Rectal temperature
of each rat was recorded using thermal digital thermo-
m e t e ra t1 ,2 ,3 ,4 ,5 ,a n d6h ra f t e rt h ea d m i n i s t r a t i o n
of the test materials, 1% SCMC, and reference drug.
Statistical analysis
All quantitative variables were presented as mean ±
SEM. Comparison of all quantitative variables between
the groups treated with test materials or reference drugs
with the untreated control group was performed using
ANOVA, followed by post hoc scheffe test. Comparison
o ft h ep a i r e dq u a n t i t a t i v ev ariables with baseline data
after treatment was performed by paired t-test. Statisti-
cal significance level was set at a = 0.05 for all tests.
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